Acurx Pharmaceuticals, Inc. (ACXP) income statement
ACXPNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.04+0.01 (+0.97%)
Close on Nov 20, 2026Market cap $5.48MP/E –Yield –
Acurx Pharmaceuticals, Inc. financial ratios
See a number that looks wrong?